宇新股份公告称，公司2026年第一次临时股东会于1月22日召开。本次会议经第四届董事会第九次会议 决议召开，1月7日公告通知。采用现场与网络投票结合方式，截至股权登记日1月16日，公司有表决权 股份总数374,798,710股，198人出席，代表股份116,074,668股，占比30.9699%。会议审议两项议案：变 更注册资本及修改公司章程、未来三年（2025 - 2027年）股东回报规划，均获出席股东三分之二以上表 决通过。 ...

Group 1 - The first extraordinary general meeting of shareholders for 2026 was held on January 21, 2026, at the company's conference room in Changzhou, Jiangsu Province [2] - The meeting was presided over by Chairman Yu Jinkun, and the voting methods complied with the Company Law and the Articles of Association [3] - A total of 9 directors were in office, with 6 attending the meeting; the board secretary and a deputy general manager also attended [4] Group 2 - The following proposals were reviewed and approved: 1. Proposal on the expected daily related transactions for 2026 [5] 2. Proposal to change the business scope and amend the Articles of Association [6] 3. Proposal to revise the management measures for raised funds [6] - Proposal 2 was a special resolution that received more than two-thirds approval from the voting shares present at the meeting [7] - The meeting was witnessed by Jiangsu Letian Law Firm, confirming that the procedures and results were in compliance with relevant laws and regulations [7]

证券代码：603026 证券简称：石大胜华 公告编号：2026-005 石大胜华新材料集团股份有限公司 2026年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东会召开的时间：2026年1月19日 (二)股东会召开的地点：山东省东营市垦利区同兴路198号石大胜华办公楼A402室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事9人，列席9人； 2、董事会秘书列席会议；其他高管列席会议。 二、议案审议情况 (一)非累积投票议案 1、议案名称：关于确认公司2025年度与关联方之间关联交易及2026年度日常关联交易预计情况的议案 审议结果：通过 表决情况： ■ (二)涉及重大事项，5%以下股东的表决情况 ■ 本次股东会由公司董事会召集，由董事长郭天明先生主持，大会采取现场投票与 ...

Group 1 - The core point of the article is that Yingke Medical (300677) experienced a stock price decline of 2.17% on January 16, 2026, closing at 41.49 yuan with a trading volume of 123,400 shares and a transaction amount of 517 million yuan [1] Group 2 - On January 16, 2026, the main funds saw a net outflow of 20.20 million yuan, while speculative funds had a net inflow of 41.11 million yuan, and retail investors experienced a net outflow of 20.91 million yuan [2][4] - Yingke Medical held its first extraordinary general meeting of shareholders in 2026 on January 16, where a legal opinion was provided by Gao Peng (Shanghai) Law Firm regarding the meeting's procedures and results [2][3] - The meeting had 495 attendees representing 51,155,851 shares, accounting for 7.8477% of the total voting shares, and approved the proposal to purchase directors and senior management liability insurance with 99.1466% in favor [3][4]

Meeting Details - The shareholders' meeting was held on January 16, 2026, at the company's conference room located at 569 Bohai 20th Road, Binzhou, Shandong Province [1] - The meeting was chaired by the company's chairman, Mr. Song Wei, and utilized a combination of on-site and online voting methods, complying with the Company Law and the company's articles of association [1] Attendance and Voting - All 9 current directors attended the meeting, along with the company secretary and senior management [1] - The voting process for the resolutions was conducted in accordance with legal and regulatory requirements, with results deemed valid and effective by the witnessing lawyers [2] Resolutions Passed - The following resolutions were approved: 1. Amendment to the company's articles of association 2. Amendment to the rules of procedure for shareholders' meetings 3. Amendment to the rules of procedure for board meetings 4. Amendment to the compensation performance management system for directors and senior management 5. Approval of estimated daily related party transactions for 2026 [2] Special Voting Requirements - Resolutions 1 to 3 required a special resolution, needing more than 2/3 of the voting rights held by attending shareholders to pass [2] - Related party shareholders, Beijing Haina Chuan Automotive Parts Co., Ltd. and Beijing Automotive Group Co., Ltd., abstained from voting on the related party transaction resolution [2]

证券代码：000758 证券简称：中色股份 公告编号：2026-001 中国有色金属建设股份有限公司 2．本次股东会无变更以往股东会决议的情况。 一、会议召开情况 1．会议召开时间：2026年1月16日下午14:30 2．会议召开地点：北京市朝阳区安定路10号中国有色大厦6层611会议室 3．会议召集人：公司第十届董事会 4．会议召开方式：现场记名投票表决和网络投票表决相结合 5．现场会议主持人：公司董事、总经理谭耀宇先生 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 特别提示： 1．本次股东会召开期间无增加、修改提案情况，不存在否决提案的情况； 6．本次会议的召开符合《中华人民共和国公司法》《上市公司股东会规则》《深圳证券交易所股票上 市规则》及《公司章程》等有关规定。 7．公司部分董事、高级管理人员及公司聘请的见证律师出席或列席了会议。 二、会议的出席情况 股东出席的总体情况： 通过现场和网络投票的股东651人，代表股份747,597,756股，占公司有表决权股份总数的37.5594%。 其中：通过现场投票的股东3人，代 ...

证券代码：600085 证券简称：同仁堂 公告编号：2026-001 北京同仁堂股份有限公司2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东会召开的时间：2026年1月16日 (二)股东会召开的地点：北京市东城区崇外大街42号同仁堂大厦5层会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集，董事长张朝华女士主持。会议采用现场投票和网络投票相结合的表决方 式进行表决。会议的召集、召开和表决符合相关法律、法规及《北京同仁堂股份有限公司章程》的规 定。 (五)公司董事和董事会秘书的列席情况 1.公司在任董事11人，出席董事11人； 2.公司董事会秘书出席本次会议；部分高级管理人员列席本次会议。 二、议案审议情况 (一)非累积投票议案 表决情况： ■ 2.议案名称：《关于与关联方签订销售框架 ...

Meeting Details - The first temporary shareholders' meeting of Shanghai Datun Energy Co., Ltd. was held on January 16, 2026, at Radisson Hotel, Shanghai [2] - The meeting was convened by the board of directors and chaired by Mr. Zhang Futao, the chairman of the board [2] - The meeting complied with the provisions of the Company Law and the Articles of Association regarding convening, holding, and voting [2] Attendance - All 8 current directors attended the meeting [3] - The company secretary, Mr. Duan Jianjun, and some senior management personnel were also present [4] Resolutions Passed - The following proposals were approved: - Proposal on the company's 2026 daily related party transaction arrangements [5] - Proposal on conducting financial business with China Coal Finance Co., Ltd. [5] - The proposals were reviewed and approved by the company's ninth board of directors at its tenth meeting [7] Legal Verification - The meeting was witnessed by Beijing Jiayuan Law Firm, with lawyers Zhou Shuyao and Cheng Yuqi providing legal opinions [7] - The legal conclusion confirmed that the meeting's convening, procedures, qualifications of attendees, and voting processes complied with relevant laws and regulations [7]

Group 1 - The company held its first extraordinary general meeting of shareholders in 2026 on January 16, 2026, at its headquarters in Jiaxing, Zhejiang Province [2] - All resolutions presented at the meeting were approved without any objections [2] - The meeting was conducted in accordance with the Company Law and the company's articles of association, ensuring legal compliance [7] Group 2 - The meeting included the election of an independent director to the eighth board of directors, which was approved [5] - A proposal to change the registered capital and amend the articles of association was also approved [5] - The company approved the profit distribution plan for the first three quarters of 2025 and the use of idle funds for cash management [5][6] Group 3 - The company completed a share buyback plan, repurchasing 8,697,032 shares, which is 3.19% of the total share capital, at a total cost of approximately 100 million yuan [10] - Following the buyback, the total number of shares will decrease from 272,622,828 to 263,925,796, and the registered capital will be reduced accordingly [10] - The company notified creditors about the capital reduction and provided a 45-day period for them to claim their debts [11]

Group 1 - The core point of the announcement is that Sichuan Development Securities Investment Fund Management Co., Ltd. has completed its shareholding increase plan for Diou Waterhua Group Co., Ltd. [3][10] - The fund increased its holdings by 6,641,739 shares, amounting to a total investment of RMB 41,771,870.16, which represents 1.29% of the company's total share capital [10][11] - The increase was based on the fund's confidence in the long-term investment value of Diou Waterhua [5] Group 2 - The increase plan was announced on July 16, 2025, with a proposed investment range of RMB 40 million to RMB 60 million [3][6] - The fund held 27,657,037 shares before the increase, which accounted for 5.39% of the total share capital [3] - The fund's investment will not affect the company's compliance with listing conditions or control changes [11] Group 3 - The increase was executed through the Shenzhen Stock Exchange's trading system, including methods such as centralized bidding and block trading [7] - The funding for the increase came from the fund's own resources, with no specific lock-up arrangements beyond the legal requirements [8][9] - The fund committed to not reducing its holdings during the implementation period of the increase plan [9]